| 标题 |
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Xiaohua Wu; Yang Sun; Hongying Yang; Jing Wang; Hanmei Lou; et al 出版日期:2024-10-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)